Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

A specific gene mutation causes vitamin D-resistant rickets and hair loss.

A man developed alopecia areata after starting cancer treatment with vandetanib.

High-dose methotrexate can cause severe skin and nail issues.

The medication lopinavir-ritonavir may cause severe hair loss.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Skin reactions to antidepressants are common but usually not serious and can be treated.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Valproic acid can rarely cause fluid buildup around the lungs and heart.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Clofazimine effectively treated ashy dermatosis in a patient.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Oral alitretinoin is effective for certain types of chronic hand eczema, with mild side effects.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.